These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8340702)

  • 21. Prevention of neonatal hyperbilirubinemia by tin protoporphyrin IX, a potent competitive inhibitor of heme oxidation.
    Drummond GS; Kappas A
    Proc Natl Acad Sci U S A; 1981 Oct; 78(10):6466-70. PubMed ID: 6947237
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential regulation of heme oxygenase isozymes by Sn- and Zn-protoporphyrins: possible relevance to suppression of hyperbilirubinemia.
    Maines MD; Trakshel GM
    Biochim Biophys Acta; 1992 Jun; 1131(2):166-74. PubMed ID: 1610897
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tin-protoporphyrin-mediated disruption in vivo of heme oxygenase-2 protein integrity and activity in rat brain.
    Mark JA; Maines MD
    Pediatr Res; 1992 Sep; 32(3):324-9. PubMed ID: 1408470
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo fate of hemopexin and heme-hemopexin complexes in the rat.
    Potter D; Chroneos ZC; Baynes JW; Sinclair PR; Gorman N; Liem HH; Muller-Eberhard U; Thorpe SR
    Arch Biochem Biophys; 1993 Jan; 300(1):98-104. PubMed ID: 8424694
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Zinc protoporphyrin: A metabolite with a mission.
    Labbé RF; Vreman HJ; Stevenson DK
    Clin Chem; 1999 Dec; 45(12):2060-72. PubMed ID: 10585337
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sn-protoporphyrin rapidly and markedly enhances the heme saturation of hepatic tryptophan pyrrolase. Evidence that this synthetic metalloporphyrin increases the functional content of heme in the liver.
    Kappas A; Drummond GS; Sardana MK
    J Clin Invest; 1985 Jan; 75(1):302-5. PubMed ID: 3965510
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Disposition of tin-protoporphyrin and suppression of hyperbilirubinemia in humans.
    Anderson KE; Simionatto CS; Drummond GS; Kappas A
    Clin Pharmacol Ther; 1986 May; 39(5):510-20. PubMed ID: 3698459
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined iron sucrose and protoporphyrin treatment protects against ischemic and toxin-mediated acute renal failure.
    Zager RA; Johnson AC; Frostad KB
    Kidney Int; 2016 Jul; 90(1):67-76. PubMed ID: 27165818
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Haptoglobin and hemopexin inhibit vaso-occlusion and inflammation in murine sickle cell disease: Role of heme oxygenase-1 induction.
    Belcher JD; Chen C; Nguyen J; Abdulla F; Zhang P; Nguyen H; Nguyen P; Killeen T; Miescher SM; Brinkman N; Nath KA; Steer CJ; Vercellotti GM
    PLoS One; 2018; 13(4):e0196455. PubMed ID: 29694434
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tin-protoporphyrin: a potent inhibitor of hemoprotein-dependent steroidogenesis in rat adrenals and testes.
    Maines MD; Trakshel GM
    J Pharmacol Exp Ther; 1992 Feb; 260(2):909-16. PubMed ID: 1371161
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of oral administration of tin and zinc protoporphyrin on neonatal and adult rat tissue heme oxygenase activity.
    Vreman HJ; Hintz SR; Kim CB; Castillo RO; Stevenson DK
    J Pediatr Gastroenterol Nutr; 1988; 7(6):902-6. PubMed ID: 3199276
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term administration of massive doses of Sn-protoporphyrin in anemic mutant mice (sphha/sphha).
    Sassa S; Drummond GS; Bernstein SE; Kappas A
    J Exp Med; 1985 Sep; 162(3):864-76. PubMed ID: 3839840
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fluorometric measurement of tin-protoporphyrin in biological samples.
    Simionatto CS; Anderson KE; Sassa S; Drummond GS; Kappas A
    Anal Biochem; 1984 Aug; 141(1):213-9. PubMed ID: 6496929
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of hemoglobin and hematin on plasma clearance of hemopexin, photo-inactivated hemopexin and albumin (38575).
    Liem HH; Spector JI; Conway TP; Morgan WT; Muller-Eberhard U
    Proc Soc Exp Biol Med; 1975 Feb; 148(2):519-22. PubMed ID: 1121503
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sn-protoporphyrin use in the management of hyperbilirubinemia in term newborns with direct Coombs-positive ABO incompatibility.
    Kappas A; Drummond GS; Manola T; Petmezaki S; Valaes T
    Pediatrics; 1988 Apr; 81(4):485-97. PubMed ID: 3281127
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatic uptake of heme and hemopexin but not albumin.
    Liem HH
    Biochim Biophys Acta; 1974 May; 343(3):546-50. PubMed ID: 4407260
    [No Abstract]   [Full Text] [Related]  

  • 37. Chemoprevention of neonatal jaundice: potency of tin-protoporphyrin in an animal model.
    Drummond GS; Kappas A
    Science; 1982 Sep; 217(4566):1250-2. PubMed ID: 6896768
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sn-protoporphyrin suppresses chemically induced experimental hepatic porphyria. Potential clinical implications.
    Galbraith RA; Drummond GS; Kappas A
    J Clin Invest; 1985 Dec; 76(6):2436-9. PubMed ID: 4077989
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sn-protoporphyrin blocks the increase in serum bilirubin levels that develops postnatally in homozygous Gunn rats.
    Sisson TR; Drummond GS; Samonte D; Calabio R; Kappas A
    J Exp Med; 1988 Mar; 167(3):1247-52. PubMed ID: 3127524
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of tin (IV)-protoporphyrin-IX on bilirubin production and excretion in the rat.
    Whitington PF; Moscioni AD; Gartner LM
    Pediatr Res; 1987 May; 21(5):487-91. PubMed ID: 3588088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.